Image - Barts and The London logo and link to home page Image - divider Image - divider
  Image - Wolfson Institute of Preventive Medicine title and link to Institute home page
Images - preventive medicine, people
  Image - Centre for Environmental and Preventive Medicine title and link to Centre homepage
Centre for Environmental and Preventive Medicine: publications 2007
Alberman, E. & Mutch, L. Commentary on the revised versions of the definition and classification of cerebral palsy, Dev.Med.Child Neurol.Suppl, vol. 109, p. 32.
Barnes, I. M., Bestwick, J. P., & Larsen, S. O. Setting truncation limits for marker values in medical screening, J.Med.Screen., vol. 14, no. 2, pp. 103-106.
Bayston, R., Russell, A., Wald, N. J., & Hoffbrand, A. V. Folic acid fortification and cancer risk, Lancet, vol. 370, no. 9604, p. 2004.
Carnes, D., Parsons, S., Ashby, D., Breen, A., Foster, N. E., Pincus, T., Vogel, S., & Underwood, M. Chronic musculoskeletal pain rarely presents in a single body site: results from a UK population study, Rheumatology.(Oxford), vol. 46, no. 7, pp. 1168-1170.
Crane, E. & Morris, J. K. Paternal age and birth defects: how strong is the association, Hum.Reprod., vol. 22, no. 8, pp. 2349-2350.
Dickinson, C. J. Intracerebral haemorrhage revisited, QJM., vol. 100, no. 11, pp. 715-719.
Dickinson, C. J. Invited editorial: 'Essential hypertension: is it all in the brain?' in 'Hypertension: Cross-Talk Between the Brain and Other Organs', Dialog Cardiovasc Med, vol. 12, no. 3, pp. 159-161.
Dickinson, C. J. What can clinical medicine give back to physiology?, Physiol News no. 66, pp. 18-20.
Hajek, P., McRobbie, H., & Gillison, F. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user, Prev.Med, vol. 44, no. 3, pp. 230-234.
Lamb, S. E., Gates, S., Underwood, M. R., Cooke, M. W., Ashby, D., Szczepura, A., Williams, M. A., Williamson, E. M., Withers, E. J., Mt, I. S., & Gumber, A. Managing Injuries of the Neck Trial (MINT): design of a randomised controlled trial of treatments for whiplash associated disorders, BMC.Musculoskelet.Disord., vol. 8, p. 7.
Law, M. R., Morris, J. K., & Wald, N. J. Calcium channel blockers and headache, Br.J.Clin.Pharmacol., vol. 63, no. 2, pp. 157-158.
MacCallum, P., Madhani, M., Mt-Isa, S., & Ashby, D. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin, Pharmacoepidemiol.Drug Saf, vol. 16, no. 7, pp. 786-789.
Marlow, N., Hennessy, E. M., Bracewell, M. A., & Wolke, D. Motor and executive function at 6 years of age after extremely preterm birth, Pediatrics, vol. 120, no. 4, pp. 793-804.
McRobbie, H. & Hajek, P. Effects of rapid smoking on post-cessation urges to smoke, Addiction, vol. 102, no. 3, pp. 483-489.
Morris, J. K. & Wald, N. J. The effect of correlations between screening markers on screening performance, J.Med Screen, vol. 14, no. 3, pp. 151-157.
Morris, J. K. & Wald, N. J. Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004, J.Med Screen., vol. 14, no. 2, pp. 55-59.
Morris, J. K. & Wald, N. J. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies, J.Med Screen., vol. 14, no. 1, pp. 5-7.
Paton, J. F., Waki, H., Abdala, A. P., Dickinson, J., & Kasparov, S. Vascular-brain signaling in hypertension: role of angiotensin II and nitric oxide, Curr.Hypertens.Rep., vol. 9, no. 3, pp. 242-247.
Wald, D. S. Problems with performance related pay in primary care, BMJ, vol. 335, no. 7619, p. 523.
Wald, D. S. The future of coronary heart disease prevention, Clin.Med, vol. 7, no. 4, pp. 392-396.
Wald, D. S., Bestwick, J. P., & Wald, N. J. Familial hypercholesterolaemia: screening needs a fresh approach, BMJ, vol. 335, no. 7628, pp. 1007-1008.
Wald, D. S., Bestwick, J. P., & Wald, N. J. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis, BMJ, vol. 335, no. 7620, p. 599.
Wald, D. S., Morton, G., Walker, K., Iosson, N., & Curzen, N. P. Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease, Ann.Pharmacother., vol. 41, no. 10, pp. 1644-1647.
Wald, N. Neonatal screening: old dogma or sound principle?, Pediatrics, vol. 119, no. 2, pp. 406-407.
Wald, N. Paying for publication, J.Med Screen., vol. 14, no. 1, p. 1.
Wald, N. J. Screening: a step too far. A matter of concern, J.Med Screen., vol. 14, no. 4, pp. 163-164.
Wald, N. J. & Oakley, G. P. Should folic acid fortification be mandatory? Yes, BMJ, vol. 334, no. 7606, p. 1252.
Wald, N. J., Bestwick, J. P., Barnes, I. M., & Kellner, L. H. Anomalous marker patterns in Down syndrome screening, Prenat.Diagn., vol. 27, no. 2, pp. 185-186.
Wald, N. J., Bestwick, J. P., & Morris, J. K. Truncation limits for CT marker ratios in prenatal screening for Down syndrome, Prenat.Diagn., vol. 27, no. 2, pp. 187-188.
Weisz, B., Pandya, P. P., David, A. L., Huttly, W., Jones, P., & Rodeck, C. H. Ultrasound findings after screening for Down syndrome using the integrated test, Obstet.Gynecol., vol. 109, no. 5, pp. 1046-1052.
Weisz, B., Pandya, P., Chitty, L., Jones, P., Huttly, W., & Rodeck, C. Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice, BJOG., vol. 114, no. 4, pp. 493-497.

Useful links:
  WIPM publications hub

by Wolfson Institute Website Manager © Queen Mary, University of London 2011
Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London, Charterhouse Square, London EC1M 6BQ Tel: 020 7882 3850 Fax: 020 7882 6270